1. 1320. In Vitro Activity of Lefamulin against Staphylococcus aureus Isolated from the Lower Respiratory Tract of Children with Cystic Fibrosis. (4th December 2021) Authors: Sader, Helio S; Paukner, Susanne; Gelone, Steven P; Arends, S J Ryan; Mendes, Rodrigo E Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1353. In Vitro Activity of Lefamulin (LEF) Against Bacterial Pathogens Commonly Causing Community-Acquired Bacterial Pneumonia (CABP): 2016 SENTRY Data From the United States. (26th November 2018) Authors: Paukner, Susanne; Flamm, Robert K; Gelone, Steven P; Sader, Helio S Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1365. In Vitro Activity of Lefamulin (LEF) Against Bacterial Pathogens Causing Community-Acquired Bacterial Pneumonia (CABP): SENTRY Surveillance 2016 Results From Asia-Pacific (APAC) and Latin America (LA). (26th November 2018) Authors: Paukner, Susanne; Flamm, Robert K; Gelone, Steven P; Sader, Helio S Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1689. In Vitro Activity of Lefamulin Against Bacterial Pathogens Collected From Pneumonia Patients in United States and Latin America Medical Centers in 2020-2021. (15th December 2022) Authors: Paukner, Susanne; Ryan Arends, S J; Mendes, Rodrigo E; Gelone, Steven P; Sader, Helio S Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2189. Anti-inflammatory Activity of Lefamulin in a Mouse Model of Influenza Virus H1N1 Infection. (15th December 2022) Authors: Wicha, Wolfgang W; Kimber, Sandy; Cumper, Charlotte; Lam, Hon S; Ballesteros, Lorena S; Kirkham, Christopher; Richards, Claire; Gelone, Steven P; Paukner, Susanne Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2386. Efficacy of Lefamulin (LEF) vs. Moxifloxacin (MOX) Against Common Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Results From the Phase 3 Lefamulin Evaluation Against Pneumonia (LEAP 1) Study. (26th November 2018) Authors: File, Thomas; Goldberg, Lisa; Paukner, Susanne; Das, Anita; Gelone, Steven P; Saviski, John; Sweeney, Carolyn; Seltzer, Elyse; Talbot, George H; Gasink, Leanne B Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant S. pneumoniae in Ambulatory and Hospitalized Adult Patients in the United States. (4th February 2021) Authors: Gupta, Vikas; Yu, Kalvin C; Schranz, Jennifer; Gelone, Steven P Journal: Open forum infectious diseases Issue: Volume 8:Number 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study. Issue 1 (1st February 2001) Authors: Nyirjesy, Paul; Sobel, Jack D; Weitz, M Velma; Leaman, Deborah J; Small, Maria J; Gelone, Steven P Journal: Sexually transmitted infections Issue: Volume 77:Issue 1(2001) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial. (18th October 2019) Authors: File, Thomas M; Goldberg, Lisa; Das, Anita; Sweeney, Carolyn; Saviski, John; Gelone, Steven P; Seltzer, Elyse; Paukner, Susanne; Wicha, Wolfgang W; Talbot, George H; Gasink, Leanne B Journal: Clinical infectious diseases Issue: Volume 70:Number 11(2020) Page Start: 2459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials. (29th August 2022) Authors: Howard-Anderson, Jessica; Hamasaki, Toshimitsu; Dai, Weixiao; Collyar, Deborah; Rubin, Daniel; Nambiar, Sumathi; Kinamon, Tori; Hill, Carol; Gelone, Steven P; Mariano, David; Baba, Takamichi; Holland, Thomas L; Doernberg, Sarah B; Chambers, Henry F; Fowler, Vance G; Evans, Scott R; Boucher, Helen W Journal: Clinical infectious diseases Issue: Volume 76:Number 3(2023) Page Start: e1157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗